Diverse Oncogenic Fusions and Distinct Gene Expression Patterns Define the Genomic Landscape of Pediatric Papillary Thyroid Carcinoma
暂无分享,去创建一个
A. Shlien | D. Malkin | F. Fuligni | J. Wasserman | E. Propst | R. de Borja | O. Mete | P. Campisi | R. Chami | N. Wolter | V. Forte | Nathaniel D. Anderson | S. Davidson | A. Stošić | Meryl Acker | Richard de Borja
[1] X. Qiu,et al. Immunoglobulin Expression in Cancer Cells and Its Critical Roles in Tumorigenesis , 2021, Frontiers in Immunology.
[2] S. Sherman,et al. Distant metastases from childhood differentiated thyroid carcinoma: clinical course and mutational landscape. , 2020, The Journal of clinical endocrinology and metabolism.
[3] A. Alzahrani,et al. Genetic Alterations in Pediatric Thyroid Cancer Using a Comprehensive Childhood Cancer Gene Panel. , 2020, The Journal of clinical endocrinology and metabolism.
[4] J. Wasserman,et al. Lung metastasis in children with differentiated thyroid cancer: factors associated with diagnosis and outcomes of therapy. , 2020, Thyroid : official journal of the American Thyroid Association.
[5] P. Vlcek,et al. RET, NTRK, ALK, BRAF and MET fusions in a large cohort of pediatric papillary thyroid carcinomas. , 2020, Thyroid : official journal of the American Thyroid Association.
[6] E. Christison-Lagay,et al. Recurrence and Complications in Pediatric and Adolescent Papillary Thyroid Cancer in a High-Volume Practice. , 2020, The Journal of surgical research.
[7] V. Vasko,et al. PKA Activates AMPK Through LKB1 Signaling in Follicular Thyroid Cancer , 2019, Front. Endocrinol..
[8] Simion I. Chiosea,et al. Characterization of Thyroid Cancer Driven by Known and Novel ALK Fusions. , 2019, Endocrine-related cancer.
[9] R. Gong,et al. Association between TERT promoter mutations and clinical behaviors in differentiated thyroid carcinoma: a systematic review and meta-analysis , 2019, Endocrine.
[10] B. Haas,et al. Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods , 2019, Genome Biology.
[11] M. Rugge,et al. Differentiated Thyroid Carcinoma in Pediatric Age: Genetic and Clinical Scenario , 2019, Front. Endocrinol..
[12] J. Biegel,et al. Novel TRIM24-MET Fusion in a Neonatal Brain Tumor. , 2019, JCO precision oncology.
[13] M. Luster,et al. Management Guidelines for Children With Thyroid Nodules and Differentiated Thyroid Cancer , 2018, Pediatrics.
[14] A. Alzahrani,et al. Lung Metastasis in Pediatric Thyroid Cancer: Radiological Pattern, Molecular Genetics, Response to Therapy, and Outcome , 2018, The Journal of clinical endocrinology and metabolism.
[15] Nicola D. Roberts,et al. Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors , 2018, Science.
[16] Y. Nikiforov,et al. Mouse Model of Poorly Differentiated Thyroid Carcinoma Driven by STRN-ALK Fusion. , 2018, The American journal of pathology.
[17] Douglas B. Evans,et al. Thyroid cancer in adolescents and young adults , 2018, Pediatric blood & cancer.
[18] J. Wasserman,et al. Young age is associated with increased rates of residual and recurrent paediatric differentiated thyroid carcinoma , 2018, Clinical Endocrinology.
[19] Quan-Yong Luo,et al. Pulmonary metastases in children and adolescents with papillary thyroid cancer in China: prognostic factors and outcomes from treatment with 131I , 2018, Endocrine.
[20] A. Drilon,et al. RET fusions in a small subset of advanced colorectal cancers at risk of being neglected , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[21] W. Foulkes,et al. DICER1 Mutations Are Frequent in Adolescent-Onset Papillary Thyroid Carcinoma , 2018, The Journal of clinical endocrinology and metabolism.
[22] Krishanpal Anamika,et al. FusionHub: A unified web platform for annotation and visualization of gene fusion events in human cancer , 2018, PloS one.
[23] A. Dobrovic,et al. Optimizing Amplification of the GC-Rich TERT Promoter Region Using 7-Deaza-dGTP for Droplet Digital PCR Quantification of TERT Promoter Mutations. , 2018, Clinical chemistry.
[24] M. Reinalda,et al. Papillary Thyroid Carcinoma (PTC) in Children and Adults: Comparison of Initial Presentation and Long-Term Postoperative Outcome in 4432 Patients Consecutively Treated at the Mayo Clinic During Eight Decades (1936–2015) , 2018, World Journal of Surgery.
[25] C. Antonescu,et al. TFG‐MET fusion in an infantile spindle cell sarcoma with neural features , 2017, Genes, chromosomes & cancer.
[26] R. Lloyd,et al. WHO classification of tumours of endocrine organs , 2017 .
[27] A. Bauer. Molecular Genetics of Thyroid Cancer in Children and Adolescents. , 2017, Endocrinology and metabolism clinics of North America.
[28] A. Hackshaw,et al. Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer , 2017, Oncogene.
[29] M. Hirokawa,et al. Frequent BRAFV600E and Absence of TERT Promoter Mutations Characterize Sporadic Pediatric Papillary Thyroid Carcinomas in Japan , 2017, Endocrine Pathology.
[30] C. Longui,et al. Fusion Oncogenes Are the Main Genetic Events Found in Sporadic Papillary Thyroid Carcinomas from Children. , 2017, Thyroid : official journal of the American Thyroid Association.
[31] E. Harley,et al. Pediatric thyroid cancer: An update from the SEER database 2007-2012. , 2016, International journal of pediatric otorhinolaryngology.
[32] Sun Wook Cho,et al. Comprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid Cancers , 2016, PLoS genetics.
[33] M. Nikiforova,et al. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States , 2016, Cancer.
[34] S. Poyrazoglu,et al. Classic Architecture with Multicentricity and Local Recurrence, and Absence of TERT Promoter Mutations are Correlates of BRAFV600E Harboring Pediatric Papillary Thyroid Carcinomas , 2016, Endocrine Pathology.
[35] S. Monaco,et al. Molecular Characterization of Sporadic Pediatric Thyroid Carcinoma with the DNA/RNA ThyroSeq v2 Next-Generation Sequencing Assay , 2016, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[36] F. Waldman,et al. Mutational Analysis in Pediatric Thyroid Cancer and Correlations with Age, Ethnicity, and Clinical Presentation , 2016, Thyroid : official journal of the American Thyroid Association.
[37] L. McDaniel,et al. Mutation in BRAF and Other Members of the MAPK Pathway in Papillary Thyroid Carcinoma in the Pediatric Population. , 2016, Archives of pathology & laboratory medicine.
[38] O. Kallioniemi,et al. FusionCatcher – a tool for finding somatic fusion genes in paired-end RNA-sequencing data , 2014, bioRxiv.
[39] Steven J. M. Jones,et al. Integrated Genomic Characterization of Papillary Thyroid Carcinoma , 2014, Cell.
[40] Paul Theodor Pyl,et al. HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.
[41] M. Pelizzola,et al. DOTS-Finder: a comprehensive tool for assessing driver genes in cancer genomes , 2014, Genome Medicine.
[42] Lianbo Yu,et al. Follicular thyroid cancers demonstrate dual activation of PKA and mTOR as modeled by thyroid-specific deletion of Prkar1a and Pten in mice. , 2014, The Journal of clinical endocrinology and metabolism.
[43] Christopher E Mason,et al. Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers. , 2013, The Journal of clinical investigation.
[44] Ellen T. Gelfand,et al. The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.
[45] T. Soni Madhulatha,et al. An Overview on Clustering Methods , 2012, ArXiv.
[46] Silva Frieda,et al. Thyroid Cancer in the Pediatric Population , 2012 .
[47] G. Sassolas,et al. Oncogenic alterations in papillary thyroid cancers of young patients. , 2012, Thyroid : official journal of the American Thyroid Association.
[48] Christopher A. Maher,et al. ChimeraScan: a tool for identifying chimeric transcription in sequencing data , 2011, Bioinform..
[49] J. Franklyn,et al. Proto-oncogene PBF/PTTG1IP regulates thyroid cell growth and represses radioiodide treatment. , 2011, Cancer research.
[50] Süleyman Cenk Sahinalp,et al. deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data , 2011, PLoS Comput. Biol..
[51] Derek Y. Chiang,et al. MapSplice: Accurate mapping of RNA-seq reads for splice junction discovery , 2010, Nucleic acids research.
[52] L. Koniaris,et al. Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients. , 2009, The Journal of surgical research.
[53] M. Phillip,et al. Differentiated thyroid carcinoma in pediatric patients: comparison of presentation and course between pre-pubertal children and adolescents. , 2009, The Journal of pediatrics.
[54] Keying Ye,et al. Determining the Number of Clusters Using the Weighted Gap Statistic , 2007, Biometrics.
[55] C. Reiners,et al. Comprehensive Clinical Assessment of 740 Cases of Surgically Treated Thyroid Cancer in Children of Belarus , 2006, Annals of surgery.
[56] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[57] M. Borrello,et al. RET tyrosine kinase signaling in development and cancer. , 2005, Cytokine & growth factor reviews.
[58] J. Franklyn,et al. Pituitary tumor transforming gene binding factor: a novel transforming gene in thyroid tumorigenesis. , 2005, The Journal of clinical endocrinology and metabolism.
[59] Masahiro Ito,et al. Low frequency of BRAFT1796A mutations in childhood thyroid carcinomas. , 2004, The Journal of clinical endocrinology and metabolism.
[60] Y. Shimizu-Yoshida,et al. Novel tumorigenic rearrangement, Delta rfp/ret, in a papillary thyroid carcinoma from externally irradiated patient. , 2003, Mutation research.
[61] D. Harrison,et al. G‐protein mutations in human pituitary adrenocorticotrophic hormone‐secreting adenomas , 1995, European journal of clinical investigation.
[62] J. Cerutti,et al. ETV6-NTRK3 and STRN-ALK kinase fusions are recurrent events in papillary thyroid cancer of adult population. , 2018, European journal of endocrinology.
[63] L. Sullivan,et al. Molecular Testing for Oncogenic Gene Alterations in Pediatric Thyroid Lesions. , 2018, Thyroid : official journal of the American Thyroid Association.
[64] Keiji Suzuki,et al. Identification of Three Novel Fusion Oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, and PPFIBP2/RET, in Thyroid Cancers of Young Patients in Fukushima. , 2017, Thyroid : official journal of the American Thyroid Association.